Form 4 for TLSA Tiziana Life Sciences Ltd
Accepted 2026-08-06 09:30:02 ET · period of report 2026-08-04 · accession 0001213900-26-085950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-08-06 09:30 | 2026-08-04+ | TLSA | Elrifi Ivor | CEO | P - Purchase | $0.9922 | +321.4K | 4.79M | +7% | +$318.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-08-04 | P | A | 83,807 | $0.97 | 4,556,068 | I By trust | — | — | |
| 2 | Common | COMMON STOCK | 2026-08-05 | P | A | 237,616 | $1.00 | 4,793,684 | I By trust | — | — |